semaglutide autoimmune disease GLP-1 and Disease: Evidence & Provider Guidance 6 weeks micro dosing Semaglutide

Unlike older weight loss drugs that target a single hormone pathway, retatrutide activates three separate receptors: GLP-1 (glucagon like peptide 1), which slows digestion and reduces appetite GIP (glucose dependent insulinotropic polypeptide), which helps regulate blood sugar and insulin release Glucagon, which increases energy expenditure and supports fat burning By working on all three pathways together, retatrutide aims to produce a stronger combined effect than medicines that only target one or two of these hormones, such as semaglutide or tirzepatide

The signal is absent or minimal at lower doses

- -1 ,

BMC Nephrol 2024;25:130

The short answer: they belong to entirely different drug classes and were designed for different purposes

Peppermint Oil: Peppermint oil is used as the main source of flavor